Related Experiment Video
Updated: Oct 19, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Outcomes after Early Anticonvulsant Discontinuation in Aneurysmal Subarachnoid Hemorrhage
Sherry Hsiang-Yi Chou1, Julius Gene Silva Latorre2, Gulhan Alpargu3
1Departments of Critical Care Medicine, Neurology, and Neurosurgery, University of Pittsburgh School of Medicine, USA.
Insights
Early discontinuation of anticonvulsant (AED) in select subarachnoid hemorrhage (SAH) patients is safe and feasible. This approach is linked to improved outcomes, including lower mortality and higher discharge-to-home rates.
Area of Science:
- Neurology
- Neurosurgery
- Critical Care Medicine
Background:
- Anticonvulsant (AED) use for seizure prophylaxis in aneurysmal subarachnoid hemorrhage (SAH) is debated.
- Potential negative impacts of AEDs on SAH outcomes necessitate further investigation.
Purpose of the Study:
- To assess the safety and feasibility of early AED discontinuation in a specific SAH patient cohort.
- To evaluate the impact of AED discontinuation on seizure incidence, mortality, and functional outcomes.
Main Methods:
- A cohort of 166 SAH patients was analyzed.
- Early AED discontinuation was performed in awake patients following commands post-aneurysm treatment.
- Logistic regression and data partitioning were used to validate findings on seizure incidence, mortality, and functional outcomes.
Main Results:
- Seventy-three patients underwent AED discontinuation, with similar baseline characteristics to those continuing AEDs, except for lower Hunt-Hess grade.
- No seizures occurred in the AED discontinuation group (0/73) versus 1% in the AED group (1/93).
- AED discontinuation was independently associated with significantly lower mortality (2.7% vs 24%) and higher odds of discharge home (p=0.0002).
Conclusions:
- Early AED discontinuation in awake, responsive SAH patients post-treatment is safe and feasible.
- This strategy is associated with improved hospital discharge outcomes.
- Further prospective studies are warranted to confirm if empiric AED use impacts functional status negatively.
Background:
Empiric use of anticonvulsant (AED) for seizure prophylaxis in aneurysmal subarachnoid hemorrhage (SAH) remains controversial and may be associated with worse SAH outcome. We determined the safety and feasibility of early discontinuation of empiric AED in a select cohort of SAH patients.
Methods:
In a cohort of 166 consecutive SAH patients, a subset underwent early AED discontinuation if they were awake and following commands after aneurysm treatment. We examined the effect of AED discontinuation on seizure incidence, mortality and functional outcome at discharge using logistic regression and validated results using 70%-30% data partition.
Results:
Seventy-three subjects underwent AED discontinuation. Patient groups had similar gender, age, Fisher grade, incidence of craniotomy, vasospasm, ischemic infarct, intraventricular and intraparenchymal hemorrhages. Hunt-Hess (HH) grade were lower in AED-discontinuation group. Clinical or electrographic seizure occurred in 1/93 (1%) patients on AED and 0/73 patient in AED-discontinuation group. Crude mortality was 24% in patients on AED and 2.7% off AED. After adjusting for age, HH grade, vasospasm, ischemic infarct, intracerebral, and intraventricular hemorrhage, AED discontinuation remains independently associated with lower mortality and higher odds of discharge to home (p=0.0002). AED use is not associated with angiographic vasospasm on exploratory analysis.
Conclusion:
AED discontinuation in SAH patients who are awake and following commands post aneurysm treatment is safe, feasible, and associated with better outcome at hospital discharge. A larger, prospective study is necessary to determine if empiric AED use in SAH leads to poorer functional status.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm IV: Nursing Management
Aneurysm III: Interprofessional Care

